Tag Archives: liver

Merck's Keytruda hits the skids in pivotal trial, putting its liver cancer nod at risk

Merck & Co.’s immunotherapy Keytruda has been hitting its trial targets so often, it’s tempting to think it can’t miss. But it can—and Tuesday’s data in liver cancer proves it. In a pivotal study in patients with advanced hepatocellular cancer (HCC) who’d already been treated with another drug, Keytruda fell short of statistical significance on both its… Read More »

Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

[unable to retrieve full-text content]People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness of antiretroviral treatment, a French study has reported in the journal Hepatology. The study also found that people with… Read More »